Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.28 - $2.31 $12,800 - $23,100
-10,000 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.82 - $3.5 $30,758 - $59,150
-16,900 Reduced 62.83%
10,000 $23,000
Q3 2021

Nov 12, 2021

BUY
$2.59 - $3.36 $6,993 - $9,072
2,700 Added 11.16%
26,900 $71,000
Q2 2021

Aug 06, 2021

BUY
$3.11 - $4.87 $3,110 - $4,870
1,000 Added 4.31%
24,200 $83,000
Q1 2021

May 14, 2021

BUY
$3.66 - $7.67 $14,274 - $29,913
3,900 Added 20.21%
23,200 $94,000
Q4 2020

Feb 12, 2021

BUY
$3.03 - $5.51 $58,478 - $106,343
19,300 New
19,300 $85,000

Others Institutions Holding GNPX

About Genprex, Inc.


  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $112M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.